Compare ARW & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARW | BRKR |
|---|---|---|
| Founded | 1935 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.7B |
| IPO Year | 1994 | 2000 |
| Metric | ARW | BRKR |
|---|---|---|
| Price | $219.09 | $56.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $136.00 | $48.54 |
| AVG Volume (30 Days) | 749.1K | ★ 2.7M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ 49.93 | N/A |
| EPS | ★ 4.55 | 0.02 |
| Revenue | ★ $30,852,935,000.00 | $1,895,600,000.00 |
| Revenue This Year | $13.55 | $6.30 |
| Revenue Next Year | $4.58 | $3.81 |
| P/E Ratio | ★ $49.32 | $2,998.00 |
| Revenue Growth | ★ 10.49 | N/A |
| 52 Week Low | $101.79 | $28.53 |
| 52 Week High | $233.30 | $64.54 |
| Indicator | ARW | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 60.59 | 65.43 |
| Support Level | $108.96 | $46.84 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 7.71 | 3.04 |
| MACD | -0.76 | 1.06 |
| Stochastic Oscillator | 53.39 | 64.99 |
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the global components business and the global enterprise computing solutions.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.